These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8693341)

  • 1. Theophylline: taking it to a new level.
    Messerschmidt K
    S D J Med; 1996 Jun; 49(6):201-2. PubMed ID: 8693341
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of Unilair in general practice conditions. Treatment of chronic obstructive airway diseases with theophylline].
    Gregori P; Hader S; Samiri H; Wiemann M; Yousif MJ; Kiebart M
    Fortschr Med; 1997 Jan; 115(1-2):54-5. PubMed ID: 9102383
    [No Abstract]   [Full Text] [Related]  

  • 3. [Bamifylline in the treatment of chronic bronchial obstruction: a controlled clinico-functional study versus an anhydrous theophylline administered once a day].
    Caputi M; Cautiero V; Aliberti M; Monici Preti PA; Oliani C
    Arch Monaldi Mal Torace; 1988; 43(5):409-21. PubMed ID: 3079283
    [No Abstract]   [Full Text] [Related]  

  • 4. Theophylline-induced stuttering.
    Gérard JM; Delecluse F; Robience Y
    Mov Disord; 1998 Sep; 13(5):847-8. PubMed ID: 9756159
    [No Abstract]   [Full Text] [Related]  

  • 5. [Kombipek in the therapy of patients with broncho-obstructive lung diseases].
    Chuchalin AG; Tsoĭ AN; Zaĭtseva TM; Titova EV; Medani SM; Smirnov MV; Kaziakhmedov EA
    Ter Arkh; 1995; 67(6):26-9. PubMed ID: 7667774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic action of a new xanthine derivative in respiratory pathology].
    Cesco G; Biondi T; Mazzini R
    Clin Ter; 1986 Aug; 118(4):253-7. PubMed ID: 3530620
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bamifylline in the therapy of asthmatic syndromes. Efficacy and side effects vs delayed-action theophylline anhydride].
    Alciato P; Cantone PA; Fico D; Gagliardini R; Petrella V
    Minerva Med; 1990; 81(1-2):93-7. PubMed ID: 2314621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The grade of dyspnea in patients treated with a theophylline derivative (bamifylline) vs controlled-absorption theophylline].
    Giosuè S; Parola D; Cafaggi R; Astengo D; Greco G; D'Onofrio V
    Clin Ter; 1987 Dec; 123(6):457-63. PubMed ID: 2972503
    [No Abstract]   [Full Text] [Related]  

  • 9. Standards of laboratory practice: theophylline and caffeine monitoring. National Academy of Clinical Biochemistry.
    Pesce AJ; Rashkin M; Kotagal U
    Clin Chem; 1998 May; 44(5):1124-8. PubMed ID: 9590396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Theophylline in treatment of bronchial obstructive diseases].
    Rogala B
    Wiad Lek; 1998; 51(3-4):117-21. PubMed ID: 9658984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Toxic dermatitis induced by bamifylline. 2 cases].
    Carsuzaa F; Schranz J
    Presse Med; 1993 Mar; 22(10):494. PubMed ID: 8511075
    [No Abstract]   [Full Text] [Related]  

  • 12. Bronchodilator effects of terbutaline and theophylline alone and in combination in patients with chronic obstructive lung disease.
    Baadsgaard O; Oberg B; Thomsen L; Klitgaard N; Simonsen E
    Allergol Immunopathol (Madr); 1985; 13(6):471-4. PubMed ID: 2870630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Theophylline and selective phosphodiesterase inhibitor in therapy of obstructive respiratory tract diseases].
    Rabe KF; Dent G; Magnussen H
    Pneumologie; 1997 Mar; 51(3):303-16. PubMed ID: 9173421
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use and abuse of bronchodilators].
    Leuenberger P
    Schweiz Rundsch Med Prax; 1986 Jul; 75(30-31):911-3. PubMed ID: 3738341
    [No Abstract]   [Full Text] [Related]  

  • 15. [Bronchodilators: theophylline derivatives].
    Neijens HJ
    Ned Tijdschr Geneeskd; 1986 Nov; 130(46):2068-71. PubMed ID: 3796739
    [No Abstract]   [Full Text] [Related]  

  • 16. Choosing a drug regimen for obstructive pulmonary disease. 1. Agents to achieve bronchodilatation.
    Plummer AL
    Postgrad Med; 1978 Apr; 63(4):36-41, 44-6, 48. PubMed ID: 24835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controversies in pulmonary medicine. Patients with COPD should be started initially on anticholinergic bronchodilators.
    Chapman KR; Wanner A
    Am Rev Respir Dis; 1988 Oct; 138(4):1074-5. PubMed ID: 2904777
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmacotherapy of chronic obstructive pulmonary disease.
    Theodore AC; Beer DJ
    Clin Chest Med; 1986 Dec; 7(4):657-71. PubMed ID: 2878760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The death of low-dose oral theophylline for COPD?
    The Lancet Respiratory Medicine
    Lancet Respir Med; 2018 Jul; 6(7):479. PubMed ID: 29976440
    [No Abstract]   [Full Text] [Related]  

  • 20. [The relationships between the broncholytic and diuretic effects of theophylline in patients with obstructive lung diseases combined with oxalosis].
    Pospekhova GP; Kaiukov IG; Sinitsina TM; Razorenova TS
    Ter Arkh; 1997; 69(3):47-9. PubMed ID: 9229830
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.